日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Radiation Oncology Follow-Up of Prostate Cancer Survivors Following Completion of Radiotherapy: A Population-Based Study

放射肿瘤学对前列腺癌幸存者完成放射治疗后的随访:一项基于人群的研究

Cerasuolo, Joshua O; Sussman, Jonathan; Dayes, Ian S; Sutradhar, Rinku; Zargoush, Manaf; Seow, Hsien

Etiquette in the Context of Death and Dying: Communication and Conversation

临终关怀中的礼仪:沟通与对话

Dayes, Jennifer; Keenan, Joseph; Sadza, Michal; Croucher, Karina

Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials

预测前列腺癌放射治疗的剂量反应:在随机 III 期 NRG/RTOG 0126 和 SAKK 09/10 试验中验证放射特征

Dal Pra, A; Ghadjar, P; Ryu, H M; Proudfoot, J A; Hayoz, S; Michalski, J M; Spratt, D E; Liu, Y; Schär, C; Berlin, A M; Zwahlen, D R; Simko, J P; Hölscher, T; Efstathiou, J A; Polat, B; Sandler, H M; Hildebrandt, G; Parliament, M B; Mueller, A-C; Dayes, I S; Plasswilm, L; Correa, R J M; Robertson, J M; Karrison, T G; Davicioni, E; Hall, W A; Feng, F Y; Pollack, A; Thalmann, G N; Nguyen, P L; Aebersold, D M; Tran, P T; Zhao, S G

Long-Term Results of NRG/RTOG 9601, a Randomized Trial of Radiation With or Without Antiandrogens in Patients Receiving Salvage Prostate Bed Radiation Therapy Postprostatectomy

NRG/RTOG 9601 的长期结果:一项关于前列腺切除术后接受挽救性前列腺床放射治疗的患者接受放射治疗联合或不联合抗雄激素治疗的随机试验

Lukka, Himanshu R; Pugh, Stephanie L; Shipley, William U; Major, Pierre P; Sartor, Oliver; Dayes, Ian S; Bahary, Jean-Paul; Efstathiou, Jason A; Pisansky, Thomas M; Zeitzer, Kenneth L; Lawton, Colleen A F; Dess, Robert T; Camarata, Andrew S; Balogh, Alexander G; Souhami, Luis; Rosenthal, Seth A; Pennington, J Daniel; Seiferheld, Wendy F; Feng, Felix Y; Sandler, Howard M

Primary Analysis of (NCT03380806) a Phase II Randomized Trial of Stereotactic Body Radiotherapy Boost Versus Conventional Fractionation External Beam Radiotherapy Boost in Unfavorable-Intermediate and High-Risk Prostate Cancer

一项针对预后不良的中危和高危前列腺癌患者的立体定向放射治疗强化与常规分割外照射放射治疗强化的II期随机试验(NCT03380806)的主要分析

Gouveia, Andre; Mesci, Aruz; Isfahanian, Naghmeh; Dayes, Ian; Quan, Kimmen; Goldberg, Mira; Schnarr, Kara Lynne; Lukka, Himu; Cuthbert, David; Hallock, Abhiram; Douvi, Georgia; Wright, Jim; Swaminath, Anand; Chow, Tom; Diamond, Kevin; Hajdok, George; Maharaj, Lindsay; Ewusie, Joycelyne; Tsakiridis, Theodoros

Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer

局部前列腺癌立体定向放射治疗的3期临床试验

van As, Nicholas; Griffin, Clare; Tree, Alison; Patel, Jaymini; Ostler, Peter; van der Voet, Hans; Loblaw, Andrew; Chu, William; Ford, Daniel; Tolan, Shaun; Jain, Suneil; Camilleri, Philip; Kancherla, Kiran; Frew, John; Chan, Andrew; Naismith, Olivia; Armstrong, John; Staffurth, John; Martin, Alexander; Dayes, Ian; Wells, Paula; Price, Derek; Williamson, Emily; Pugh, Julia; Manning, Georgina; Brown, Stephanie; Burnett, Stephanie; Hall, Emma

Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer

NRG Oncology RTOG 0415 的长期分析:一项比较两种分割放疗方案治疗低危前列腺癌患者的随机 III 期非劣效性研究

Lee, W Robert; Dignam, James J; Amin, Mahul B; Bruner, Deborah W; Low, Daniel; Swanson, Gregory P; Shah, Amit B; D'Souza, David; Michalski, Jeff M; Dayes, Ian S; Seaward, Samantha A; Hall, William A; Nguyen, Paul L; Pisansky, Thomas M; Faria, Sergio L; Chen, Yuhchyau; Rodgers, Joseph P; Sandler, Howard M

Erratum to: Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY. Genomic classifier performance in intermediate-risk prostate cancer: results from NRG Oncology/RTOG 0126 randomized phase 3 trial. Int J Radiat Oncol Biol Phys 2023;117:370-377

勘误:Spratt DE、Liu VYT、Michalski J、Davicioni E、Berlin A、Simko JP、Efstathiou JA、Tran PT、Sandler HM、Hall WA、Thompson DJS、Parliament MB、Dayes IS、Correa RJM、Robertson JM、Gore EM、Doncals DE、Vigneault E、Souhami L、Karrison TG、Feng FY. 中危前列腺癌基因组分类器性能:NRG Oncology/RTOG 0126 随机 3 期试验结果。Int J Radiat Oncol Biol Phys 2023;117:370-377

Spratt, Daniel E; Liu, Vinnie Y T; Michalski, Jeff; Davicioni, Elai; Berlin, Alejandro; Simko, Jeffry P; Efstathiou, Jason A; Tran, Phuoc T; Sandler, Howard M; Hall, William A; Thompson, Darby J S; Parliament, Matthew B; Dayes, Ian S; Correa, Rohann Jonathan Mark; Robertson, John M; Gore, Elizabeth M; Doncals, Desiree E; Vigneault, Eric; Souhami, Luis; Karrison, Theodore G; Feng, Felix Y

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Setting

加拿大乳腺癌诊疗指南:HER2阳性乳腺癌早期和转移期患者系统治疗的国家共识建议

Manna, Mita; Gelmon, Karen A; Boileau, Jean-François; Brezden-Masley, Christine; Cao, Jeffrey Q; Jerzak, Katarzyna J; Prakash, Ipshita; Sehdev, Sandeep; Simmons, Christine; Bouganim, Nathaniel; Brackstone, Muriel; Cescon, David W; Chia, Stephen; Dayes, Ian S; Edwards, Scott; Hilton, John; Joy, Anil Abraham; Laing, Kara; Webster, Marc; Henning, Jan-Willem

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer

加拿大乳腺癌诊疗指南:新诊断乳腺癌患者临床分期的国家共识建议

Cao, Jeffrey Q; Surgeoner, Brae; Manna, Mita; Boileau, Jean-François; Gelmon, Karen A; Brackstone, Muriel; Brezden-Masley, Christine; Jerzak, Katarzyna J; Prakash, Ipshita; Sehdev, Sandeep; Wong, Stephanie M; Bouganim, Nathaniel; Cescon, David W; Chia, Stephen; Dayes, Ian S; Joy, Anil Abraham; Henning, Jan-Willem